Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Class: T.Y.BMS
Subject: Entrepreneurship
Management
Entrepreneur: Kiran
Mazumdar Shaw
(Chairman & M.D of Biocon
Limited)
What is Entrepreneur?
The word entrepreneur originates from the French word,
entreprendre, which means "to undertake." In a business context, it
means to start a business. The Merriam-Webster Dictionary
presents the definition of an entrepreneur as one who organizes,
manages, and assumes the risks of a business or enterprise.
Entrepreneur a person, who has initiative in investment and
decision to the enterprise; seeking all resource of factor of
production, resources of Management, Behavior, Cultural,
Economical and Political factor for establishing, innovation and
founded enterprise, having assumption of risk, profit and future
growth.
According to A Schumpeter “The entrepreneurship is essentially a
creative activity or it is an innovative function”.
According to Michael Gerber “The entrepreneur is our visionary,
the creator in each of us. We're born with that quality and it defines
our lives as we respond to what we see, hear, feel, and experience.
It is developed, nurtured, and given space to flourish or is
squelched, thwarted, without air or stimulation, and dies.”
Entrepreneur Quotes
"An entrepreneur tends to bite off a little more than he can chew
hoping he'll quickly learn how to chew it." - Roy Ash
"In the modern world of business, it is useless to be a creative,
original thinker unless you can also sell what you create." - David
Ogilvy
As a civic activist, she has been involved in various programs to improve the
city of Banglaore, such as the Bangalore Agenda Task Force (BATF).
She was recently named among TIME magazine’s 100 most influential
people in the world. She is also on the Forbes list of the world’s 100 most
powerful women, and the Financial Times’ top 50 women in business list.
She entered into more than 2,200 high-value R&D licensing and other deals
within the pharmaceuticals and bio-pharmaceutical space between 2005 and
2010 and helped Biocon expand its global footprint to emerging and
developed markets through acquisitions, partnerships and in-licensing. Her
belief that healthcare needs can only be met with affordable innovation has
been the driving philosophy that has helped Biocon manufacture and market
drugs cost-effectively.
ACHIEVEMENTS
Nikkei Asia Prizes- Regional Growth by Nikkiei Inc. (2009)
Wharton Infosys Business transformation Award (2006)
Padma Bhusan (2005)
Honorary Doctrate from Manipal Acadamy of Higher education –
MAHE (2005)
Life time Acheivement Award from Indian chamber of Commerce
(2005)
Honorary Doctorate of Science from Ballart Universty (2004)
The Economic Times Business Women of the year (2004)
Whirpool GR8 women award for science and technology (2004)
Australian Alumni High Achiever Award from the IDP Australian
Alumni Association (2003)
Ernst & Young Entrepreneur of the Year Award in Healthcare &
Life Sciences Category (2002)
Woman of the Year from the International Women's Association,
Chennai (1998–1999)
Padma Shri (1989)
Outstanding Young Person Award by Jaycees (1987)
Rotary award for the Best Model Employer (1983)
Outstanding Contribution Award (AWAKE) (1983)
Gold for Best Woman Entrepreneur, Institute of Marketing
Management (1982)
India's richest woman with an estimated worth of Rs. 2,100 crore.
OtherActivities
In 2004, she started the Biocon Foundation to conduct health, education,
sanitation, and environment programs for the benefit of the economically
weaker sections of society. The Foundation’s micro-health insurance
program has an enrolment of 70,000 rural members.
Its 7 ARY clinics are located where healthcare facilities are poor and offer
clinical care, generic medicines and basic tests for those who cannot afford
them. Each of the clinics serves a population of 50,000 people living within
a radius of 10 km. All the clinics organize regular general health checks in
remote villages by bringing in physicians and doctors from network
hospitals. Each year, the Foundation touches more than 300,000 lives
through its holistic healthcare approach.
She helped establish a 1,400-bed cancer care center at the Narayana Health
City campus at Boommasandra, Bangalore, along with Dr. Devi Shetty of
Narayana Hrudayalaya in 2007. Called the Mazumdar Shaw Cancer Centre
(MSCC), it is one of the largest cancer hospitals of its kind, spread as it is
over an area of five lakh square feet. It specializes in head and neck cancer,
breast cancer and cervical cancer.
Market Share
Biocon shares are currently trading at 408.20 as on 24th dec 2010.current
market value of share is Rs. 8,164 cr. Shares of biocon were listed at issue
price of Rs.400.
Biocon went for an IPO to raise Rs 300 crores to fund its huge capital
expansion plans.
Recent Articles
Pfizer, Biocon in $350 million insulin pact
MUMBAI: The world's largest drug manufacturer, Pfizer Inc, has entered into a $350-
million global agreement to market Bangalore-based Biocon's biosimilar versions of
insulin for diabetes treatment.
This is Pfizer's fourth marketing deal with a domestic company — after Aurobindo ,
Claris LifeSciences and Strides Arcolab — and also first biotech deal from India.
Under the agreement, announced on Monday, Pfizer will make upfront payments totaling
$200 million and an additional development and regulatory milestone payments of up to
$150 million which will be linked to sales (of biosimilar insulin) across global markets.
Drug MNCs, faced with slowing sales in their home markets, are aggressively focusing
on emerging markets by entering into such supply agreements.
Pfizer will hold exclusive rights to commercialize insulin products like recombinant
human insulin, Glargine, Aspart and Lispro globally, except in certain markets. It will co-
market the products with Biocon in Germany, India and Malaysia, a joint statement by
the companies said.
The hospital, which started operations two weeks ago, has been named after Kiran
Mazumdar Shaw, CMD of Biocon, who has put in Rs 40 crore into this project. It
currently has 500 beds, but will eventually become a 5-lakh sq ft, 1,400-bed facility,
making it perhaps the world's largest cancer hospital. It will focus on cancer related to
head, neck, breast and cervix, has qualified in-house doctors, and draws medical expertise
from world renowned medical universities like Cornell.
Dr Devi Prasad Shetty, chairman of Narayana Hrudayalaya, said that cancer is the most
common cause of death after cardiovascular disease. Unfortunately cancer is detected at a
late stage, significantly increasing the possibility of mortality.
The cost per patient is expected to be lower for the Shetty-Shaw hospital because of the
large scale of the operations. "More than 5,000 patients are expected to visit the centre
every day," Shetty said.
Stressing on the need to set standards, Dr Anthony Pais, head of the women's oncology
section, said that 45% of the breast cancer surgeries in hospitals are done by surgeons
who have not specialized in breast cancer. "There is a need to aim for standards. And this
Centre will work towards that," he said.
Kiran Mazumdar Shaw, who is said to have given the idea to Dr Shetty to start a cancer
hospital, has donated Rs 40 crore for the hospital. "A much more comprehensive,
research-based treatment protocol is required for a balance between making medical
assistance and developing an effective cancer treatment. The centre will look into
evolving new techniques, early detection, conduct clinical trials and research," she said.